
Strategies for managing crossborder reporting obligations.

US banking regulators have altered some aspects of their supervisory stances, eliminating reputational risk as a standalone basis for supervisory criticism, among other moves.
Julie DiMauro3 min read

Principal third-party disclosure mechanisms and the common pitfalls for pharmaceutical compliance and risk teams.

Supervision, enforcement, and the need to embrace outcomes-focused conduct.
Kerry Berchem | Burges Salmon4 min read

The order, mandates a crackdown on “debanking” and ends the use of reputational risk in regulatory oversight.
Alexander Barzacanos1 min read

GRIP’s US Content Manager Julie DiMauro speaks with Karen Brown, Head of KYC compliance at a New York correspondent bank.
Julie DiMauro18 min listen

Maybe reputation has loomed too large in risk assessment but, says Julie DiMauro, it would be unwise to disregard it entirely.
Julie DiMauro3 min read

Criminal convictions for a former McKinsey partner and ex-Volkswagen directors for compliance failings and misconduct.
Jean Hurley2 min read